News
If your printer ink isn't long past the expiration date, chances are it's still wet and completely usable. The reason printer ink expires is that it dries up slowly and can't be used to print ...
(RTTNews) - Applied Digital Corp. (APLD) has signed two long-term lease agreements with AI hyperscaler CoreWeave, under which it will deliver 250 megawatts or MW of IT capacity at its Ellendale ...
The partnership between ASP and Isotopia is aimed at addressing supply challenges for Gd-160, enabling Isotopia to advance Tb-161-based therapies for prostate cancer, neuroendocrine tumours and ...
You hear most conversations about the past radiate around how fun radio used to be. Today, we focus on business and rightfully so. But that old saying is still true: “Don’t throw the baby out ...
SASKATOON - Alberta and Saskatchewan signed agreements with Ontario on Sunday to remove trade barriers ahead of a meeting with Prime Minister Mark Carney to hash out a plan they hope will ...
Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the Multicloud The Future of the Internet ...
Regarding cobalt chloride, according to SMM spot quotes, cobalt chloride quotes also declined significantly this week compared to the past. As of May 30, the spot quote for cobalt chloride fell to ...
It is expected that next week, the spot price of cobalt sulphate may fluctuate and weaken. This week, the price of cobalt chloride decreased. From the supply side, quotations from major smelters ...
The New York Times on Thursday announced that it will license content from across its newsroom to train Amazon AI models. Under the multi-year deal, Amazon’s AI services like Alexa will be able ...
Oklo signed an MOU with Korea Hydro & Nuclear Power (KHNP) to advance and deploy its nuclear technology globally. The collaboration will focus on standard design, verification, and early-stage ...
TCG Labs Soleil’s Juri Biosciences is offering EpimAb Biotherapeutics up to $210 million biobucks for exclusive licensing rights to the China biotech’s T-cell engager designed to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results